Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:SIGYNASDAQ:STRROTCMKTS:USAQNASDAQ:WOK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSIGYSigyn Therapeutics$3.53$4.07$3.15▼$6.34$5.67M-1.04436 shsN/ASTRRStar Equity$2.16+8.0%$2.16$1.72▼$5.35$6.44M0.6713,800 shs61,610 shsUSAQQHSLab$0.19$0.22$0.07▼$0.47$1.97M0.922,410 shsN/AWOKWORK Medical Technology Group LTD Ordinary Shares$0.42+2.8%$0.55$0.36▼$8.45$6.03MN/A921,312 shs81,603 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSIGYSigyn Therapeutics0.00%-14.94%-14.94%+10.31%-41.17%STRRStar Equity+3.40%+9.70%-4.42%+0.51%-52.55%USAQQHSLab-0.01%+5.31%-25.57%-2.07%+55.71%WOKWORK Medical Technology Group LTD Ordinary Shares+2.76%-2.12%-25.53%-81.63%+42,439,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationSIGYSigyn TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ASTRRStar Equity2.1254 of 5 stars0.05.00.00.03.01.71.3USAQQHSLab0.2844 of 5 stars0.03.00.00.00.61.70.0WOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceSIGYSigyn Therapeutics 0.00N/AN/AN/ASTRRStar Equity 0.00N/AN/AN/AUSAQQHSLab 0.00N/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary Shares 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookSIGYSigyn TherapeuticsN/AN/AN/AN/A($2.80) per shareN/ASTRRStar Equity$53.36M0.13$0.35 per share6.11$14.63 per share0.15USAQQHSLab$1.41M1.40N/AN/A($0.04) per share-4.65WOKWORK Medical Technology Group LTD Ordinary Shares$11.51M0.54N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateSIGYSigyn Therapeutics-$4.15M-$4.77N/A∞N/AN/AN/A-1,147.41%N/ASTRRStar Equity$25.13M-$3.91N/AN/AN/A-12.41%-8.72%-4.62%5/19/2025 (Estimated)USAQQHSLab-$470K-$0.03N/A∞N/A-3.24%N/A-3.43%N/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest USAQ, SIGY, STRR, and WOK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/19/2025Q1 2025STRRStar Equity-$0.25N/AN/AN/A$16.35 millionN/A4/15/2025Q4 2024SIGYSigyn TherapeuticsN/A-$2.51N/A-$2.51N/AN/A3/28/2025Q4 2024USAQQHSLabN/A-$0.03N/A-$0.03N/A$0.63 million3/20/2025Q4 2024STRRStar Equity-$0.17$0.15+$0.32-$0.94$14.00 million$17.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthSIGYSigyn TherapeuticsN/AN/AN/AN/AN/ASTRRStar EquityN/AN/AN/AN/AN/AUSAQQHSLabN/AN/AN/AN/AN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioSIGYSigyn TherapeuticsN/A0.060.05STRRStar Equity0.212.051.60USAQQHSLabN/A0.170.15WOKWORK Medical Technology Group LTD Ordinary SharesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipSIGYSigyn Therapeutics10.01%STRRStar Equity3.84%USAQQHSLabN/AWOKWORK Medical Technology Group LTD Ordinary SharesN/AInsider OwnershipCompanyInsider OwnershipSIGYSigyn Therapeutics78.46%STRRStar Equity33.51%USAQQHSLab74.19%WOKWORK Medical Technology Group LTD Ordinary SharesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableSIGYSigyn Therapeutics51.61 million346,000Not OptionableSTRRStar Equity4603.22 million2.14 millionNot OptionableUSAQQHSLab510.59 million2.73 millionNot OptionableWOKWORK Medical Technology Group LTD Ordinary Shares22614.59 millionN/AN/AUSAQ, SIGY, STRR, and WOK HeadlinesRecent News About These CompaniesWORK Medical Technology Group LTD Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 11, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025March 5, 2025 | globenewswire.comWORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.February 28, 2025 | globenewswire.comWORK Medical Technology Group LTD Reports Financial Results for Fiscal Year 2024February 14, 2025 | prnewswire.comWORK Medical Technology Group LTD's Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024November 27, 2024 | globenewswire.comWORK Medical Technology Group LTD Announces Partial Exercise of Underwriters' Over-Allotment OptionAugust 29, 2024 | globenewswire.comWORK Medical Technology Group LTD Announces Closing of Initial Public OfferingAugust 26, 2024 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUSAQ, SIGY, STRR, and WOK Company DescriptionsSigyn Therapeutics OTCMKTS:SIGY$3.53 0.00 (0.00%) As of 04/29/2025Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.Star Equity NASDAQ:STRR$2.16 +0.16 (+8.00%) As of 04/30/2025 04:00 PM EasternStar Equity Holdings, Inc. engages in the construction business in the United States and internationally. It operates through two segments: Construction, and Investments. It manufactures modular housing units, structural wall panels, permanent wood foundation systems, and other engineered wood products; supplies general contractors with building materials; holds real estate assets; and manages investments. The company was formerly known as Digirad Corporation and changed its name to Star Equity Holdings, Inc. in December 2020. Star Equity Holdings, Inc. was founded in 1985 and is headquartered in Old Greenwich, Connecticut.QHSLab OTCMKTS:USAQ$0.19 0.00 (0.00%) As of 04/29/2025QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK$0.42 +0.01 (+2.76%) As of 04/30/2025 02:22 PM EasternWORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hims & Hers Stock Soars on Novo Nordisk Collaboration 3 Dividend Kings Outshining the Market in 2025 Tesla's Band-Aid Has Been Ripped Off: Rally Mode Engaged Amazon's Earnings Will Make or Break the Stock's Comeback Why D-Wave's Project With Davidson Is a Game-Changer For Quantum NXP Semiconductors: A Buy-and-Hold Stock in the Buy Zone Joby Aviation Shares Eye Breakout After Transition Flight Win Altria’s Resilient Strategy Keeps It a Top Dividend Play in 2025 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
